A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Human Journals Research Article September
To compare the effects of an insulin sensitizer, metformin, with an insulin secretagogue, Glimepiride, on Glycosylated hemoglobin level (HbA1c) and lipid profile in type II diabetes patients. This is a prospective cross sectional study carried out on 120 type II diabetic Patients were selected according to the prescription divided in three groups Metformin (N=40), Glimepiride (N=40), a combination of Glimepiride with metformin (N=40). We observed the levels of HbA1c and lipid profiles, in the 0fatcat:2paw2gw5vjgtphp4icndwecdoe